Abstract
In the last years, a new technology such as the remote monitoring (RM) is developed and permits surveillance and device assessment from any location of the patient. RM is important to facilitate early diagnosis of arrhythmia and evaluate earlier than in-office visit problems with the device or leads.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilkoff BL et al (2009) Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm 6(7):1085–1104
Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J et al (2012) ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 14:278–293
Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al (2008) HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5:907–925
Krebsbach A, Alhumaid F, Henrikson CA, Calkins H, Berger RD, Cheng A (2011) Premature failure of a Riata defibrillator lead without impedance change or inappropriate sensing: a case report and review of the literature. J Cardiovasc Electrophysiol 22:1070–1072
Hauser RG, McGriff D, Retel LK (2012) Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. Heart Rhythm 9:742–749
Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO et al (2005) Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112(6):841–848
Crossley GH, Chen J, Choucair W et al (2009) Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol 54(22):2012–2019. doi:10.1016/j.jacc.2009.10.001
Varma N, Epstein A, Irimpen A, Schweikert R, Shah J, Love CJ, TRUST Investigators (2010) Efficacy and safety of automatic remote monitoring for ICD follow-up: the TRUST trial. Circulation 122:325–332
Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, CONNECT Investigators (2011) Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181–1189
Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A et al (2012) Remote monitoring reduces healthcare utilization and improves quality of care in heart failure patients with implantable defibrillators: the EVOLVO (Evolution of Management Strategies of Heart Failure Patients with Implantable Defibrillators) Study. Circulation 125:2985–2992
Ricci RP, Morichelli L, Santini M (2009) Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace 11:54–61
Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A et al (2012) A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 33:1105–1111
ECkstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S et al (2008) Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117(21):2727–2733
Maisel WH, Kramer DB (2008) Implantable cardioverter-defibrillator lead performance. Circulation 117(21):2721–2723
Ricci RP, Morichelli L, Santini M (2008) Home Monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace 10(2):164–170
Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Rishel R et al (2011) Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 17(2):51–55
Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM et al (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 32(18):2266–2273
van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G et al.; DOT-HF Investigators (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124(16):1719–1726
Brachmann J, Böhm M, Rybak K, Klein G, Butter C, Klemm H et al (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 13(7):796–804
Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB et al.; PARTNERS Study Investigators (2010) Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 55(17):1803–1810
Simons EC, Feigenblum DY, Nemirovsky D, Simons GR (2009) Alert tones are frequently inaudible among patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 32(10):1272–1275
Healey JS, Connolly SJ, Gold MR, IsraelCW, Van Gelder IC Capucci A et al.; for the ASSERT Investigators (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366:120–129
Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida JS et al (2013) A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 34(8):605–614. doi:10.1093/eurheartj/ehs425
Schron EB, Exner DV, Yao Q, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105:589–594
Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GY, Blomstrom-Lundqvist C (2014) Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 16(1):129–132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cipolletta, L., Ricciotti, J. (2015). The Role of Home Monitoring. In: Capucci, A. (eds) Clinical Cases in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-19926-9_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-19926-9_28
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19925-2
Online ISBN: 978-3-319-19926-9
eBook Packages: MedicineMedicine (R0)